Pharmascience Canada is proud to announce the launch of Pr pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) and perennial ...
Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...